HCA Healthcare Inc (NYSE:HCA) – Equities researchers at Oppenheimer issued their Q1 2019 earnings estimates for HCA Healthcare in a research note issued to investors on Tuesday. Oppenheimer analyst M. Wiederhorn anticipates that the company will earn $1.86 per share for the quarter. Oppenheimer currently has a “Buy” rating and a $90.00 target price on the stock. Oppenheimer also issued estimates for HCA Healthcare’s Q2 2019 earnings at $1.93 EPS, Q3 2019 earnings at $1.79 EPS, Q4 2019 earnings at $2.16 EPS and FY2019 earnings at $7.74 EPS.
HCA has been the subject of several other reports. Morgan Stanley cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $85.00 price objective for the company. in a research note on Wednesday, December 20th. Credit Suisse Group restated an “outperform” rating and issued a $25.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 26th. KeyCorp restated an “overweight” rating and issued a $90.00 price objective (down from $95.00) on shares of HCA Healthcare in a research note on Thursday, October 19th. Citigroup upgraded HCA Healthcare from a “neutral” rating to a “buy” rating in a research note on Tuesday, December 12th. Finally, Cantor Fitzgerald restated a “buy” rating and issued a $90.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 31st. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and seventeen have given a buy rating to the company’s stock. HCA Healthcare currently has a consensus rating of “Buy” and an average target price of $88.32.
HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, October 31st. The company reported $1.21 earnings per share for the quarter, hitting the consensus estimate of $1.21. The business had revenue of $10.70 billion during the quarter, compared to the consensus estimate of $10.70 billion. HCA Healthcare had a negative return on equity of 47.16% and a net margin of 6.13%. The company’s quarterly revenue was up 4.1% on a year-over-year basis. During the same quarter last year, the company earned $1.45 earnings per share.
A number of hedge funds have recently made changes to their positions in HCA. Northwestern Mutual Wealth Management Co. increased its position in shares of HCA Healthcare by 14.0% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock valued at $101,000 after buying an additional 143 shares in the last quarter. Atlantic Trust LLC purchased a new stake in shares of HCA Healthcare in the second quarter valued at approximately $118,000. Acrospire Investment Management LLC increased its position in shares of HCA Healthcare by 14.3% in the second quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock valued at $140,000 after buying an additional 200 shares in the last quarter. BB&T Investment Services Inc. purchased a new stake in shares of HCA Healthcare in the second quarter valued at approximately $141,000. Finally, D.A. Davidson & CO. increased its position in shares of HCA Healthcare by 37.7% in the second quarter. D.A. Davidson & CO. now owns 1,970 shares of the company’s stock valued at $171,000 after buying an additional 539 shares in the last quarter. Institutional investors own 75.35% of the company’s stock.
In related news, insider Michael S. Cuffe sold 2,400 shares of HCA Healthcare stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $86.63, for a total transaction of $207,912.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Victor L. Campbell sold 8,000 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, November 8th. The shares were sold at an average price of $78.00, for a total value of $624,000.00. Following the transaction, the senior vice president now owns 127,275 shares of the company’s stock, valued at $9,927,450. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 20,550 shares of company stock valued at $1,606,172. 2.90% of the stock is owned by company insiders.
About HCA Healthcare
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.